ACS Medicinal Chemistry Letters · 2019 · 18 citations · 25 references
MedicineMedicinal ChemistryPharmacologyDrug DiscoveryMolecular PharmacologyNeuropharmacologyLigand BindingMolecular Targets Of DrugsNeurotransmitter ReceptorsProtein-ligand BindingReceptor PharmacologyReceptor-ligand Interactions5-Hydroxytryptamine Receptor PharmacologyCell Survival AssaysDrug Receptor PharmacologyG-protein-coupled ReceptorsGpcr SelectivityLigand-receptor AffinityReceptor Selectivity ProfilingReceptor-ligand Selectivity
The phenethylamine backbone is a privileged substructure found in a wide variety of G protein-coupled receptor (GPCR) ligands. This includes both endogenous neurotransmitters and active pharmaceutical agents. More than 20 structurally unique heterocyclic phenethylamine derivatives were broadly evaluated for GPCR affinity. Selective ligands for the 5-HT2B, 5-HT7, and σ1 receptors were identified, each with low nanomolar binding affinities. The σ1 receptor affinity was supported in a cellular assay that provided evidence for increased cell survival under oxidative stress.
25
Valvular Heart Disease Associated with Fenfluramine–Phentermine
Heidi M. Connolly, Jack L. Crary, Michael D. McGoon et al. · New England Journal of Medicine · 1997 · 1.6K citations · Full text
Automated design of ligands to polypharmacological profiles
Jérémy Besnard, G.F. Ruda, Vincent Setola et al. · Nature · 2012 · 845 citations · Full text
Pharmacogenomics of GPCR Drug Targets
Alexander S. Hauser, Sreenivas Chavali, Ikuo Masuho et al. · Cell · 2017 · 649 citations · Full text